Market revenue in 2023 | USD 3.9 million |
Market revenue in 2030 | USD 6.1 million |
Growth rate | 6.6% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 58.97% in 2023. Horizon Databook has segmented the Mexico bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The rising incidence of respiratory diseases, such as COPD, asthma, and lung cancer, is a primary driver of the bronchial biopsy device market in Mexico. For instance, lung cancer is one of the leading causes of cancer-related deaths in the country, as reported by the Mexican Ministry of Health.
This high disease burden underscores the need for advanced diagnostic tools to enable early and accurate detection. Consequently, hospitals and clinics are increasingly adopting sophisticated bronchial biopsy devices to address this growing demand. According to data from GLOBOCAN, around 190,667 cancer cases are reported in Mexico annually.
Moreover, technological innovation is transforming the bronchial biopsy landscape. Devices such as EBUS and electromagnetic navigation bronchoscopes represent significant advancements. For instance, EBUS allows for real-time imaging and guidance during biopsy procedures, enhancing diagnostic precision.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into Mexico bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account